Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Allergen-specific T cell response to Dermatophagoides pteronyssinus proteins" refers to the complex immune reaction mediated by various subsets of **T helper cells** and **regulatory T cells** that specifically recognize antigens from *Dermatophagoides pteronyssinus*—a major species of house dust mite implicated in allergic diseases. These responses are highly heterogeneous and include both pro-inflammatory Th2-type reactions that drive allergy/asthma pathology and regulatory mechanisms that can dampen inflammation or promote tolerance. For example, increased numbers of interleukin‑9–producing Th2 cells have been observed in individuals with HDM allergy and asthma[1]. Conversely, certain interferon-responsive Th subsets expressing TRAIL may help restrain pathogenic Th2 responses. Regulatory T cells—including both thymus-derived Foxp3+ types and peripherally induced Tr1 types—play key roles in maintaining tolerance by producing anti-inflammatory cytokines like IL‑10 and transforming growth factor β[2]. The balance between these effector and regulatory populations determines whether exposure leads to allergic disease or immunotolerance. Note: This entry describes an **immune process**, not a discrete molecular entity such as a receptor or enzyme. Therefore it is not considered a canonical therapeutic target but rather an important functional readout for understanding disease mechanisms or monitoring therapy efficacy[1][3].
Not a single molecule; mechanisms involve modulation of immune pathways, e.g., via allergen immunotherapy or biologics targeting cytokines involved in the response[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allergen-specific T cell response to Dermatophagoides pteronyssinus proteins.